cryptocurrency innovation, Top

Modern Pharmaceuticals: Sinopharm Zhijun, the holding subsidiary, obtained the drug registration certificate of Cefotaxime Tablets. Modern Pharmaceuticals announced that Sinopharm Zhijun Pharmaceutical Co., Ltd., the holding subsidiary, recently received the Drug Registration Certificate of Cefotaxime Tablets approved and issued by National Medical Products Administration. Cefopoxime axetil tablets are the third generation cephalosporins taken orally, which are used to treat upper respiratory tract infections and lower respiratory tract infections caused by sensitive bacteria. In 2023, the global sales of preparations will be USD 370 million, and the sales of public hospitals nationwide will be RMB 102 million. The accumulative R&D investment of Sinopharm Zhijun is about RMB 28.45 million. Obtaining the registration certificate will enrich the company's product line, increase market competitiveness and have a positive impact on the company's future development. However, drug sales are easily affected by factors such as policies and market environment, and there are uncertainties.South Korea's chaebol triggered public outrage among investors, and regulators began to show their swords and rectify. For half a century, South Korea's oligarchs have dominated almost every economic field. They are in charge of corporate giants, making waves in political circles, carefully planning mysterious business transactions, and sacrificing the interests of shareholders while making profits for themselves. Regulators and investors began to show their swords. South Korean President Yin Xiyue announced that martial law was hastily lifted, or faced the fate of stepping down. The current political situation may accelerate this counterattack process again.Zhewen Internet: Zhejiang Internet (600986) announced on the evening of December 11th that the company intends to authorize the management of the company to make an independent decision to dispose of the stock of Doushen Education Technology (Beijing) Co., Ltd. (hereinafter referred to as "Doushen Education") held by the company through centralized bidding or block trading. The authorization period is within 36 months from the date of deliberation and approval by the shareholders' meeting. As of the date of announcement, the company holds 61.06 million shares of Doushen Education, accounting for 2.95% of the total share capital of Doushen Education, and will lift the restriction on sales on December 29, 2024.

It is reported that Walgreens Boots Alliance is negotiating to sell itself to a private equity company, which will delist the drugstore chain. The company's share price has been declining for nearly ten years. According to informed sources, Wobolian and Sycamore Partners have been discussing a deal, which may be completed as early as early next year, provided that the negotiations do not break down. It is reported that the market value of Wobolian peaked at more than 100 billion US dollars in 2015, but it has shrunk to about 7.5 billion US dollars since then.The official notification that the hospital canteen was accused of selling spoiled rice: the report lacked sufficient evidence to support it, and the illegal facts of the canteen were not established. On December 11th, the Jiangnan District Market Supervision Administration of Nanning issued a briefing saying that regarding Hou Moumou's complaint about the "selling spoiled rice" in the canteen of the Second People's Hospital of Nanning (West Hospital) on September 9th, 2024, the Jiangnan District Market Supervision Administration sampled and inspected the rice in the canteen warehouse, and the testing institution did so on September 11th. According to the circular, the investigation of the case ended on December 6, 2024, and the Jiangnan District Market Supervision Administration determined that Hou Moumou's report on "selling rotten rice" in the canteen of Nanning Second People's Hospital (West Hospital) lacked sufficient evidence to support it, and the illegal facts of the canteen were not established.The People's Procuratorate of Hunan Province decided to arrest Ye Xinping in accordance with the law. The case of Ye Xinping (director level), the former party secretary and chairman of Hunan Construction Engineering Group Co., Ltd., was investigated by Hunan Provincial Supervision Committee and transferred to the procuratorate for examination and prosecution. A few days ago, the Hunan Provincial People's Procuratorate made a decision to arrest Ye Xinping on suspicion of accepting bribes. The case is being further processed.

Robot concept stocks are active again and again, and Great Wheel Intelligence, Ningbo Jingda, Kelier and Keli Sensing have reached new heights.The dividend low-wave ETF(512890) attracted 2.35 billion yuan in the last five days, with the latest scale of 10.8 billion yuan. On December 11th, the dividend low-wave ETF(512890) rose by 0.27%, with a turnover of 234 million yuan and the latest scale of 10.8 billion yuan. In terms of capital flow, it attracted 2.35 billion yuan in the last five days and 2.81 billion yuan in the last 10 days. In the news, recently, the dividend-themed ETFs have been reported frequently. The fund sizes of Huatai Bairui Dividend ETF and Huatai Bairui Dividend Low Wave ETF, the two largest dividend-themed ETFs in the whole market, exceeded 20 billion yuan and 10 billion yuan respectively. Huatai Berry dividend ETF has become the first dividend-themed ETF with a scale of 20 billion in the whole market. Huatai Bairui Fund said that on the one hand, this year's insurance funds frequently placarded, indicating that the pace of insurance funds entering the market has accelerated; On the other hand, the yield of 10-year treasury bonds has continued to decline and has entered the "1" era. Under the low interest rate environment, it has become inevitable that medium and long-term funds will increase the overall investment income by allocating equity assets. Investors can borrow the dividend low-wave ETF(512890) and its linked funds (Class A 007466, Class C 007467) layout.It is reported that Walgreens Boots Alliance is negotiating to sell itself to a private equity company, which will delist the drugstore chain. The company's share price has been declining for nearly ten years. According to informed sources, Wobolian and Sycamore Partners have been discussing a deal, which may be completed as early as early next year, provided that the negotiations do not break down. It is reported that the market value of Wobolian peaked at more than 100 billion US dollars in 2015, but it has shrunk to about 7.5 billion US dollars since then.